and team also demonstrated that mitochondrial reprogramming through upregulation of mitochondrial pyruvate carrier was essential to restoring the functionality of exhausted CD8+ T cells, and this improved their anti‐tumor capacities.[80] Undoubtedly, future studies will need to investigate the full potential of mito‐transfer on anti‐tumor immunity. This evidence concerns the gene CD8A and neoplasm.